Are Antibodies Directed Against Amyloid-β (Aβ) Oligomers the Last Call For the Aβ Hypothesis of Alzheimer's Disease?
Year: 2018
Type: editorial
Abstract: The multiple failures of previous anti-Aβ drugs may suggest that in the AD brain, the accumulation of Aβ could be secondary to an unknown initial disrupting event."
Source: Immunotherapy
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2903753579
